Larvol Delta - Aviceda-announces-FDA-approval-of-the-Investigational-New-Drug-IND-application-for-AVD104-a-novel-glycomimetic-nanoparticle-allowing-initiation-of-Phase-2-clinical-trials-for-the-treatment-of-atrophy

AVD-104 - Aviceda

https://www.businesswire.com/news/home/20230413005671/en/IPS-HEART-receives-FDA-Rare-Pediatric-Drug-Designations-for-both-of-its-Stem-Cell-Drugs-for-Duchenne-Muscular-Dystrophy

Apr 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next